Santini, P.; Mosoni, C.; D’Errico, A.; Porceddu, E.; Lupascu, A.; Valeriani, E.; Tondi, P.; Pola, R.; Porfidia, A.
Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients. J. Clin. Med. 2023, 12, 6427.
https://doi.org/10.3390/jcm12196427
AMA Style
Santini P, Mosoni C, D’Errico A, Porceddu E, Lupascu A, Valeriani E, Tondi P, Pola R, Porfidia A.
Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients. Journal of Clinical Medicine. 2023; 12(19):6427.
https://doi.org/10.3390/jcm12196427
Chicago/Turabian Style
Santini, Paolo, Carolina Mosoni, Alessandro D’Errico, Enrica Porceddu, Andrea Lupascu, Emanuele Valeriani, Paolo Tondi, Roberto Pola, and Angelo Porfidia.
2023. "Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients" Journal of Clinical Medicine 12, no. 19: 6427.
https://doi.org/10.3390/jcm12196427
APA Style
Santini, P., Mosoni, C., D’Errico, A., Porceddu, E., Lupascu, A., Valeriani, E., Tondi, P., Pola, R., & Porfidia, A.
(2023). Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients. Journal of Clinical Medicine, 12(19), 6427.
https://doi.org/10.3390/jcm12196427
